Abata Therapeutics

Cambridge, United States

Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.

Aug 2024

Corporate Round

Biotechnology Medical Therapeutics

Top Investors

Lightspeed Venture PartnersSamsara BioCapitalInvusBristol-Myers SquibbThird Rock Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Abata Therapeutics

Who are Abata Therapeutics's investors?

Abata Therapeutics's investors include Lightspeed Venture Partners, Samsara BioCapital, Invus, Bristol-Myers Squibb, Third Rock Ventures.

Where is Abata Therapeutics headquartered?

Abata Therapeutics is headquartered in Cambridge, United States.

What does Abata Therapeutics do?

Abata Therapeutics develops regulatory T cell (Treg) therapies for treating autoimmune diseases including progressive multiple sclerosis.

What stage is Abata Therapeutics at?

Abata Therapeutics is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 15, 2024.

MLA

"Abata Therapeutics — Funding & Investors." VCBacked, August 15, 2024, https://www.vcbacked.co/company/abata-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Abata Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/abata-therapeutics

Wikipedia (cite web)

{{cite web |title=Abata Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/abata-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 15, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.